Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Terminated Phase 3 Interventional

A Study to Assess Pulsed Inhaled Nitric Oxide in Subjects With Pulmonary Fibrosis at Risk for Pulmonary Hypertension

ClinicalTrials.gov ID: NCT03267108

Public ClinicalTrials.gov record NCT03267108. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Oct 23, 2026, 7:47 AM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Randomized, Double-Blind, Placebo-Controlled Dose Escalation and Verification Clinical Study to Assess the Safety and Efficacy of Pulsed Inhaled Nitric Oxide (iNO) in Subjects at Risk of Pulmonary Hypertension Associated With Pulmonary Fibrosis on Long Term Oxygen Therapy (Part 1 and Part 2) - REBUILD

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

A randomized, double-blind, placebo-controlled dose escalation and verification study to assess the safety and efficacy of pulsed inhaled nitric oxide (iNO) in subjects at risk for pulmonary hypertension associated with pulmonary fibrosis on long term oxygen therapy (Part 1 and Part 2) - REBUILD

Study identification

NCT ID
NCT03267108
Recruitment status
Terminated
Study type
Interventional
Phase
Phase 3
Lead sponsor
Bellerophon Pulse Technologies
Industry
Enrollment
145 participants

Conditions and interventions

Interventions

Combination Product

Eligibility (public fields only)

Age range
18 Years to 80 Years
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Dec 14, 2020 (Actual)
Primary completion
Jun 9, 2023 (Actual)
Completion
Jun 30, 2023 (Actual)
Last update posted
Jul 27, 2023

2020 – 2023

United States locations

U.S. sites
61
U.S. states
27
U.S. cities
52
Facility City State ZIP Site status
University of Alabama Birmingham Alabama 35294 —
Banner - University Medical Center Arizona Phoenix Arizona 85006 —
Arizona Pulmonary Specialists, Ltd. Phoenix Arizona 85012 —
University of California San Francisco Fresno California 93701 —
University of California Los Angeles California 90024 —
Amicis Research Northridge California 91324 —
Paloma Medical Group Paloma California 92675 —
University of California Davis Health Sacramento California 95817 —
Stanford University Medical Center Stanford California 94305 —
UC Denver Anschutz Medical Center Aurora Colorado 80046 —
National Jewish Denver Colorado 80206 —
Georgetown University Washington D.C. District of Columbia 20007 —
St. Francis Sleep Allergy and Lung Institute Clearwater Florida 33765 —
Advanced Pulmonary Research Institute Loxahatchee Groves Florida 33470 —
University of Miami Miami Florida 33125 —
Avanza Medical Research Center Pensacola Florida 32503 —
University of South Florida Tampa Florida 33612 —
Cleveland Clinic Weston Florida 33331 —
Emory University Atlanta Georgia 30322 —
Northside Hospital Atlanta Georgia 30342 —
Piedmont Healthcare Austell Georgia 30106 —
Northwestern Chicago Illinois 60611 —
North Shore University Hospital Evanston Illinois 60201 —
Loyola University Maywood Illinois 60153 —
Southern Illinois University Springfield Illinois 62702 / 62794 —
Ascension St. Vincent Hospital Indianapolis Indiana 46260 —
Norton Pulmonary Specialists Louisville Kentucky 40202 —
University of Louisville Louisville Kentucky 40202 —
Johns Hopkins Hospital Baltimore Maryland 21205 —
Tufts Medical Center Boston Massachusetts 02111 —
Brigham and Women's Hospital Boston Massachusetts 02115 —
University of Michigan Ann Arbor Michigan 48109 —
Henry Ford Hospital Detroit Michigan 48202 —
The Lung Research Center, LLC Chesterfield Missouri 63017 —
Creighton University Omaha Nebraska 68124 —
Atlantic Health Respiratory Institute Summit New Jersey 07901 —
NYU Langone New York New York 10016 —
Mount Sinai Hospital New York New York 10029 —
Weill Cornell Medical Center New York New York 10065 —
Stony Brook University Hospital Stony Brook New York 11794 —
The University of North Carolina at Chapel Hill Marsico Clinical Research Center Chapel Hill North Carolina 27517 —
Pulmonix, LLC/LeBauer Cone Health Greensboro North Carolina 27403 —
University of Cincinnati Cincinnati Ohio 45267 —
University Hospitals Cleveland Ohio 44106 —
The Ohio State University Columbus Ohio 43210 —
The Oregon Clinic Portland Oregon 97220 —
Thomas Jefferson University Korman Respiratory Institute Philadelphia Pennsylvania 19017 —
University of Pennsylvania Philadelphia Pennsylvania 19104 —
Temple University Philadelphia Pennsylvania 19140 —
University of Pittsburgh Pittsburgh Pennsylvania 15123 —
AnMed Health Anderson South Carolina 29621 —
Medical University of South Carolina Charleston South Carolina 29425 —
Vanderbilt University Medical Center Nashville Tennessee 37232 —
Baylor University Medical Center Dallas Texas 75246 —
UT Southwestern Medical Center Dallas Texas 75390 —
University of Texas Health Science Center at Houston Houston Texas 77030 —
Metroplex Pulmonary and Sleep McKinney Texas 75069 —
University of Utah Health Sciences Salt Lake City Utah 84108 —
Inova Heart and Vascular Institute Advanced Lung Disease Clinic Falls Church Virginia 22042 —
Pulmonary Associates of Richmond Richmond Virginia 23229 —
University of Washington Medical Center Seattle Washington 98195 —

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Non-U.S. locations

This page focuses on the U.S. directory. The official record also lists 3 non-U.S. sites.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT03267108, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Jul 27, 2023 · Synced Oct 23, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete public registry record, listed eligibility criteria, and available contact information for NCT03267108 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →